Skip to main content

Yoojin Choi

Korea University · Medicine

About the Lab

Professor Yoojin Choi's research lab focuses on advancing cancer immunotherapy and diagnostic technologies through innovative biomedical approaches. The lab investigates cancer stem cell targeting using dendritic cell vaccines, explores the role of immunosuppressive cells like Tregs in tumor microenvironments, and develops natural compounds—such as resveratrol analogs—to overcome treatment resistance. Additionally, the lab pioneers rapid, cost-effective biosensors using nanomaterials for sensitive pathogen detection, bridging diagnostics and therapeutic strategies.

cancer immunotherapycancer stem cellsresveratrol analogsnanomaterialsbiosensors

Research Overview

Papers
204
Total Citations
2,157
Papers (5y)
82
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
82total
2022
2023
2024
2025
2026
Citations per year (5y)
315total
20222023202420252026

Selected Papers

15
1
Review|173 citations·2018
Recent Trends in Nanomaterials‐Based Colorimetric Detection of Pathogenic Bacteria and Viruses
Yoo Jin Choi, Ji Hyeon Hwang, Sang Yup Lee
SJR Q1Small MethodsOA

Rapid, sensitive, selective, convenient, and cost-effective pathogen diagnosis is important to prevent further spread of pandemic diseases, minimize social and economic losses, and to facilitate right clinical therapy. Over the past few years, various sensor-based diagnostic systems outperforming conventional pathogenic diagnostic assays have been developed. Among them, colorimetric biosensors detecting target molecules by the naked eye have attracted much attention due to their simplicity, prac

Biomedical EngineeringEngineering
2
Article|50 citations·2020
Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status
Hyeong Seok Kim, Youngmin Han, Jae Seung Kang, Yoo Jin Choi, Yoonhyeong Byun, Haeryoung Kim, Kyung Bun Lee, Hongbeom Kim, Wooil Kwon, Jin‐Young Jang
SJR Q1Annals of Surgery

OBJECTIVE: This study evaluated the associated factors and prognosis according to pathology and margin after surgical resection of intraductal papillary mucinous neoplasms (IPMN). BACKGROUND: There is limited information on recurrence patterns according to pathology and margin in IPMN. METHODS: Total 577 patients who underwent operation for IPMN at a tertiary center were included. Factors associated with recurrence, survival, and recurrence outcomes according to pathology and margin were analyze

OncologyMedicine
3
Article|49 citations·2018
EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
Yoo Jin Choi, Seong‐Joon Park, You-Soo Park, Hee Sung Park, Kwangmo Yang, Kyu Heo
SJR Q1PLoS ONEOA

Cancer stem-like cells (CSCs) may play a key role in tumor initiation, self-renewal, differentiation, and resistance to current treatments. Dendritic cells (DCs) play a vital role in host immune reactions as well as antigen presentation. In this study, we explored the suitability of using CSC peptides as antigen sources for DC vaccination against human breast cancer and hepatocellular carcinoma (HCC) with the aim of achieving CSC targeting and enhancing anti-tumor immunity. CD44 is used as a CSC

ImmunologyImmunology and Microbiology
4
Article|45 citations·2022
Artificial intelligence versus physicians on interpretation of printed ECG images: Diagnostic performance of ST-elevation myocardial infarction on electrocardiography
Yoo Jin Choi, Min Ji Park, Yura Ko, Moon-Seung Soh, Hyue Mee Kim, Chee Hae Kim, Eun‐Kyoung Lee, Joonghee Kim
SJR Q1International Journal of Cardiology
Cardiology and Cardiovascular MedicineMedicine
5
Article|32 citations·2012
Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells
Yoo Jin Choi, Kwangmo Yang, Sung‐Dae Kim, Young Hyun Yoo, Sang Wha Lee, Su Yeong Seo, Hongsuk Suh, Sung Tae Yee, Min Ho Jeong, Wol Soon Jo
Experimental and Therapeutic MedicineOA

Recent advances in the understanding of the mechanisms responsible for tumor progression suggest the possibility to control cancer growth, not only through chemotherapy-induced cancer cell destruction, but also by stimulating anticancer immunity. However, immune tolerance against tumor antigens disturbs diverse forms of immunotherapy. One of the most potent and well-studied tumor-induced immunosuppressive phenotypes found in the tumor microenvironment is the regulatory subpopulation cells (CD4(+

ImmunologyImmunology and Microbiology
6
Article|25 citations·2023
A single-center experience of over 300 cases of single-incision robotic cholecystectomy comparing the da Vinci SP with the Si/Xi systems
Yoo Jin Choi, Nguyen Thanh Sang, Hye-Sung Jo, Dong‐Sik Kim, Young‐Dong Yu
SJR Q1Scientific ReportsOA

Minimally invasive surgery is usually more beneficial than open surgeries in various fields of surgery. With the newly developed Single-Port (SP) robotic surgical system, even single-site surgery has become easier to access. We compared single-incision robotic cholecystectomy between the Si/Xi and SP systems. This retrospective single-center study enrolled patients who underwent single-incision robotic cholecystectomy between July 2014 and July 2021. The clinical outcomes of the da Vinci Si/Xi a

SurgeryMedicine
7
Article|25 citations·2019
Clinical Outcomes of Ileostomy Closure According to Timing During Adjuvant Chemotherapy After Rectal Cancer Surgery
Yoo Jin Choi, Jung‐Myun Kwak, Neul Ha, Tae Hoon Lee, Se Jin Baek, Jin Kim, Seon Hahn Kim
SJR Q2Annals of ColoproctologyOA

PURPOSE: No guidelines exist detailing when to implement a temporary ileostomy closure in the setting of adjuvant chemotherapy following sphincter-saving surgery for rectal cancer. The aim of this study was to evaluate the clinical and oncological outcomes of ileostomy closure during adjuvant chemotherapy in patients with curative resection of rectal cancer. METHODS: This retrospective study investigated 220 patients with rectal cancer undergoing sphincter-saving surgery with protective loop ile

OncologyMedicine
8
Article|25 citations·2016
The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions
Yoo Jin Choi, Kyu Heo, Hee Sung Park, Kwangmo Yang, Min Ho Jeong
SJR Q2International Journal of OncologyOA

Tumor hypoxia is associated with treatment resistance, cell proliferation, and metastatic potential, all of which contribute to a poor prognosis. Resveratrol [RES (trans-3,4',5-trihydroxystilbene)], a naturally occurring polyphenol, is enriched in grapes and red wine. This study investigated whether the resveratrol analog HS-1793 modulates the hypoxic status and the level of perfusion in mouse breast cancer FM3A cells. Our data show that HS-1793 decreased the levels of hypoxia-inducible factor-1

Geriatrics and GerontologyMedicine
9
Article|24 citations·2013
Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers
Yoo Jin Choi, Jae Hwi Song, Jung Hwan Yoon, Won Suk Choi, Suk Woo Nam, Jung Young Lee, Won Sang Park
SJR Q1Gastric CancerOA
OncologyMedicine
10
Article|23 citations·2022
Single-port robot plus one port (SP + 1) distal pancreatectomy using the new da Vinci SP system
Yoo Jin Choi, Hye-Sung Jo, Dong‐Sik Kim, Young‐Dong Yu
SJR Q2Langenbeck s Archives of Surgery
SurgeryMedicine
11
Article|21 citations·2020
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX
Yoo Jin Choi, Yoonhyeong Byun, Jae Seung Kang, Hyeong Seok Kim, Youngmin Han, Hongbeom Kim, Wooil Kwon, Do‐Youn Oh, Woo Hyun Paik, Sang Hyub Lee, Ji Kon Ryu, Yong‐Tae Kim
SJR Q1Gut and LiverOA

Background/Aims: Although many studies have reported the promising effect of neoadjuvant treatment for borderline resectable pancreatic cancer (BRPC) to increase resectability, only a few studies have recommended the use of first-line chemotherapeutic agents as neoadjuvant treatment for BRPC. The current study compared clinical outcomes between gemcitabine and FOLFIRINOX (5-fluorouracil, leucovorin, oxaliplatin, and irinotecan) in patients with BRPC. Methods: In this single-center retrospective

OncologyMedicine
12
Article|20 citations·2017
Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing
최유진, 김애리, 김진경, 이진환, 이수연, 김정렬
Journal of Breast Cancer

Purpose: Breast cancer has a high prevalence in Korea. To achieve personalized therapy for breast cancer, long-term followup specimens are needed for next-generation sequencing (NGS) and multigene analysis. Formalin-fixed paraffin-embedded (FFPE) samples are easier to store than fresh frozen (FF) samples. The objective of this study was to optimize RNA extraction from FFPE blocks for NGS. Methods: RNA quality from FF and FFPE tissues (n=5), expected RNA amount per unit area, the relationship bet

13
Article|13 citations·2016
A Case of Malignant PEComa of the Uterus Associated with Intramural Leiomyoma and Endometrial Carcinoma
Yoo Jin Choi, Jin Hwa Hong, Aeree Kim, Hankyeom Kim, Hyeyoon Chang
SJR Q2Journal of Pathology and Translational MedicineOA

Perivascular epithelioid cell tumors (PEComas) refers to a family of mesenchymal neoplasms composed of angiomyolipomas, clear cell "sugar" tumors of the lung, and lymphangioleiomyomatoses. These tumors have a distinctive and common component of perivascular epithelioid cells that show an association with blood vessel walls and immunohistochemically display myomelanocytic differentiation. The unique neoplasms have been shown to have an expanded range through a variety of case reports, including v

PhysiologyMedicine
14
Article|10 citations·2021
Diagnostic model for pancreatic cancer using a multi-biomarker panel
Yoo Jin Choi, Woongchang Yoon, Areum Lee, Youngmin Han, Yoonhyeong Byun, Jae Seung Kang, Hongbeom Kim, Wooil Kwon, Young‐Ah Suh, Yongkang Kim, Seungyeoun Lee, Junghyun Namkung
SJR Q2Annals of Surgical Treatment and ResearchOA

This diagnostic model based on the triple ELISA kit showed better diagnostic performance than previous markers for PDAC. In the future, it needs external validation to be used in the clinic.

OncologyMedicine
15
Article|10 citations·2003
Bending analysis of mindlin-reissner plates by the element free galerkin method with penalty technique
Yoo Jin Choi, Seung Jo Kim
KSME International Journal
Mechanics of MaterialsEngineering

Research Areas

OncologySurgeryMolecular BiologyEpidemiologyBiomedical EngineeringCancer Research

Dive deeper into Yoojin Choi's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.